Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133964) titled 'Analysis of factors influencing the prognosis of primary and secondary IgA nephropathy and the establishment of a prognosis prediction model' on Oct. 9.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
IgA Nephropathy, IgA Vasculitis , IgA Vasculitis Nephropathy
Intervention:
IgA Nephropathy:None
IgA Vasculitis:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2023-06-05
Target Sample Size: IgA Nephropathy:600;IgA Vasculitis:50;IgA Vasculitis Nephropathy:150;
Countries of Recruitment:
China
To know more,...